Dual inhibition of HDAC and EGFR signaling with CUDC-101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancer.
about
High-throughput drug library screening identifies colchicine as a thyroid cancer inhibitorAn epithelial marker promoter induction screen identifies histone deacetylase inhibitors to restore epithelial differentiation and abolishes anchorage independence growth in cancers.Functional Genomic Landscape of Human Breast Cancer Drivers, Vulnerabilities, and Resistance.HDAC inhibitors suppress c-Jun/Fra-1-mediated proliferation through transcriptionally downregulating MKK7 and Raf1 in neuroblastoma cells.CUDC-101, a Novel Inhibitor of Full-Length Androgen Receptor (flAR) and Androgen Receptor Variant 7 (AR-V7) Activity: Mechanism of Action and In Vivo EfficacyCarfilzomib potentiates CUDC-101-induced apoptosis in anaplastic thyroid cancerHTP Nutraceutical Screening for Histone Deacetylase Inhibitors and Effects of HDACis on Tumor-suppressing miRNAs by Trichostatin A and Grapeseed (Vitis vinifera) in HeLa cellsHDACs and HDAC Inhibitors in Cancer Development and Therapy.MicroRNAs let7 expression in thyroid cancer: correlation with their deputed targets HMGA2 and SLC5A5.Histone deacetylase 6 (HDAC6) deacetylates extracellular signal-regulated kinase 1 (ERK1) and thereby stimulates ERK1 activity.Long noncoding RNA NEAT1 promotes the metastasis of osteosarcoma via interaction with the G9a-DNMT1-Snail complex.
P2860
Q35945841-5A7F4524-22BA-4128-A0D0-EA7DBD772AC2Q36110047-8E0EB703-4644-4BC3-A587-8D7BC807EC77Q36496096-C6B0388B-BB2D-4B40-B2BD-8DF40CC12BC1Q36916322-031E3F84-98DD-414B-8E85-192498E1BF0BQ36978557-E8EF4279-A040-4834-8602-EA49CF2910EAQ37086070-F794FBF6-2B17-4BC7-A238-DA85DE8DAFB1Q37607905-DA71AD2D-9869-462F-BB39-C41480D413DFQ38947405-E340FFBB-6E2B-4B18-A06B-31CB994387AFQ39934112-06EB256F-EA17-4391-9FDF-34669A6420DBQ47273239-C3E630EC-BBA0-4DFB-AB3E-E6387E204503Q49476480-BC023863-25E4-42B5-92DC-B948EC9140C8
P2860
Dual inhibition of HDAC and EGFR signaling with CUDC-101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Dual inhibition of HDAC and EG ...... in anaplastic thyroid cancer.
@ast
Dual inhibition of HDAC and EG ...... in anaplastic thyroid cancer.
@en
type
label
Dual inhibition of HDAC and EG ...... in anaplastic thyroid cancer.
@ast
Dual inhibition of HDAC and EG ...... in anaplastic thyroid cancer.
@en
prefLabel
Dual inhibition of HDAC and EG ...... in anaplastic thyroid cancer.
@ast
Dual inhibition of HDAC and EG ...... in anaplastic thyroid cancer.
@en
P2093
P2860
P356
P1433
P1476
Dual inhibition of HDAC and EG ...... in anaplastic thyroid cancer.
@en
P2093
Amit Mehta
Electron Kebebew
Jeffrey A Kiefer
John A Copland
Lisa Zhang
Matthew B Boxer
Myriem Boufraqech
Robert C Smallridge
P2860
P304
P356
10.18632/ONCOTARGET.3268
P407
P577
2015-04-01T00:00:00Z